Bicycle Therapeutics plc American Depositary Shares (BCYC)
PHARMACEUTICAL PREPARATIONS
Bicycle Therapeutics plc American Depositary Shares (BCYC) is listed on Nasdaq, where it has traded since May 23, 2019.
- Listed On
- Nasdaq
- Listed Since
- May 23, 2019
- Employees
- 288
- Market Cap
- $258M
About Bicycle Therapeutics plc American Depositary Shares
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 104 institutions reported holding BCYC, with 37.3 million shares worth $157.9 million in aggregate. The largest reported holder was Baker Bros. Advisors, with 10.9 million shares worth $46.2 million. Of the 5 largest holders listed below, all 5 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Baker Bros. Advisors | 10,885,357 | $46M | Unchanged |
| Fcpm III Services B.V | 3,468,430 | $15M | Unchanged |
| Armistice Capital | 3,398,000 | $14M | Unchanged |
| Long Focus Capital Management | 3,310,687 | $14M | Unchanged |
| Acadian Asset Management | 1,968,025 | $8M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BCYC?
Bicycle Therapeutics plc American Depositary Shares (BCYC) is listed on Nasdaq, where it has traded since May 23, 2019.
Who are the largest institutional holders of BCYC?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BCYC were Baker Bros. Advisors, Fcpm III Services B.V and Armistice Capital.
How many institutions own BCYC?
104 institutions reported a position in BCYC for the quarter ended June 30, 2026, worth $157.9 million in total.
Did institutions buy or sell BCYC last quarter?
Of the 5 largest reported holders, all 5 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BCYC.
Every reported institutional holder, plus insider and congressional trades in BCYC, on SentiSense.